Загрузка...
Vasopressin use in critically ill cirrhosis patients with catecholamine-resistant septic shock: The CVICU cohort
AIM: To examine patient-centered outcomes with vasopressin (AVP) use in patients with cirrhosis with catecholamine-refractory septic shock. METHODS: We conducted a single center, retrospective cohort study enrolling adult patients with cirrhosis treated for catecholamine-resistant septic shock in th...
Сохранить в:
| Опубликовано в: : | World J Hepatol |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Baishideng Publishing Group Inc
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5241528/ https://ncbi.nlm.nih.gov/pubmed/28144392 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v9.i2.106 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|